Chemotherapy Results by Institution
Cooperative Osteosarcoma Studies Germany, Austria (Winkler)
Dana-Farber Cancer Institute/Children's Hospital Boston, Mass. (Jaffe, Goorin, Grier)
Nov. 1974 Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. pdf
1981 High-dose methotrexate in osteogenic sarcoma
(1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial
European Osteosarcoma Intergroup Study
Received-dose and dose intensity of chemotherapy and outcome in nonmetastatic extremity Osteosarcoma
Institute for Limb Preservation Denver, Colorado (Wilkens)
Institute for Limb Preservation 2002 Results on Osteosarcoma
Improved Survival in Primary Nonmetastatic Pediatric Osteosarcoma of the Extremity
pdf 2003
pdf 2005
Denver Protocol(1990)
|| Arteriogram
||
Overall Survival in Denver
||
Cardio-toxicity ||
Audiogram testing
Institito Orthopedico Rizzoli Italy (Bacci)
IOR Osteosarcoma results
Japan (Tschiyua)
1998 Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma
1999 Marginal excision for osteosarcoma with caffeine assisted chemotherapy1999 Japan Marginal excision for osteosarcoma with caffeine assisted chemotherapy
Caffeine 1 Caffeine 2 Caffeine 3 Caffeine 4 Caffeine 5 Caffeine 6
Memorial Sloan-Kettering NY, NY(Rosen, Myers, Huvos, Gorlick)
Meyers Memorial Sloan Kettery CC results
MD-Anderson Houston, Texas (Jaffe, Kleinerman)
1989 MD-Anderson 10 Year Protocol MD Anderson protocol
Multi-Institutional Osteosarcoma Study(Link)
1993 Multi-Institutional Osteo. Study
New Zealand
Pediatric Oncology Group (Grier, Goorin, Myers, Kleinerman, Link)
Mar. 2005 full text Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
Medunsa, South Africa
2000 Osteosarcoma in Ga-Rankuwa Hospital: a 10 year experience in an African population.
Soutwest Oncology Group
Zurich Switzerland